1. Home
  2. LXRX vs ATGL Comparison

LXRX vs ATGL Comparison

Compare LXRX & ATGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • ATGL
  • Stock Information
  • Founded
  • LXRX 1995
  • ATGL 2017
  • Country
  • LXRX United States
  • ATGL Hong Kong
  • Employees
  • LXRX N/A
  • ATGL N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • ATGL
  • Sector
  • LXRX Health Care
  • ATGL
  • Exchange
  • LXRX Nasdaq
  • ATGL Nasdaq
  • Market Cap
  • LXRX 552.4M
  • ATGL 480.7M
  • IPO Year
  • LXRX 2000
  • ATGL 2023
  • Fundamental
  • Price
  • LXRX $1.37
  • ATGL $20.03
  • Analyst Decision
  • LXRX Buy
  • ATGL
  • Analyst Count
  • LXRX 5
  • ATGL 0
  • Target Price
  • LXRX $3.23
  • ATGL N/A
  • AVG Volume (30 Days)
  • LXRX 2.6M
  • ATGL 1.6K
  • Earning Date
  • LXRX 11-04-2025
  • ATGL 01-01-0001
  • Dividend Yield
  • LXRX N/A
  • ATGL N/A
  • EPS Growth
  • LXRX N/A
  • ATGL N/A
  • EPS
  • LXRX N/A
  • ATGL N/A
  • Revenue
  • LXRX $58,432,000.00
  • ATGL $1,206,460.00
  • Revenue This Year
  • LXRX $66.55
  • ATGL N/A
  • Revenue Next Year
  • LXRX N/A
  • ATGL N/A
  • P/E Ratio
  • LXRX N/A
  • ATGL N/A
  • Revenue Growth
  • LXRX 1504.83
  • ATGL 2.36
  • 52 Week Low
  • LXRX $0.28
  • ATGL $7.58
  • 52 Week High
  • LXRX $2.08
  • ATGL $57.32
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 48.43
  • ATGL 38.93
  • Support Level
  • LXRX $1.36
  • ATGL $20.14
  • Resistance Level
  • LXRX $1.48
  • ATGL $21.68
  • Average True Range (ATR)
  • LXRX 0.10
  • ATGL 0.88
  • MACD
  • LXRX -0.02
  • ATGL -0.24
  • Stochastic Oscillator
  • LXRX 3.33
  • ATGL 5.00

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

Share on Social Networks: